Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Building a beta-lactam powerhouse: Gaelic’s strategic leap with Athlone In December 2025, Gaelic Laboratories, a world-class manufacturer of beta-lactam (penicillin) products, acquired Athlone Laboratories, another leading developer and supplier of...
  2. Biologics at a turning point: complexity, AI and the road to 2026 Despite rapid change, the growing complexity of biologics and the rise of AI-driven design are reinforcing the increasing need for deep scientific expertise and innovation...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    From pilots to production: what 2026 could mean for pharma This editorial examines predictions from the HSBC Innovation Banking Life Sciences and Healthcare team on how innovation, investment and consolidation are expected to shape the...
  4. Symbiosis begins commercial manufacturing at new FDA-inspected facility Symbiosis Pharmaceutical Services (Symbiosis), a leading sterile fill-finish contract manufacturing organisation (CMO), has manufactured its first 10,000-vial batch at the...
  5. Ofichem Group to acquire drug formulation development specialist, Avivia Ofichem will now be able to offer its clients a range of early-stage development services, from analytical method development to excipient characterisation

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

You may also like

Finance From thymus regeneration and ECM-targeted oncology to fast-scaling metabolic health technology, three European companies secure fresh capital as investors double down on...

European life sciences investors kick off 2026 with targeted bets on immunity, oncology and metabolic health

Read more
Finance This editorial examines predictions from the HSBC Innovation Banking Life Sciences and Healthcare team on how innovation, investment and consolidation are expected to shape the...

From pilots to production: what 2026 could mean for pharma

Read more
Research & Development Despite rapid change, the growing complexity of biologics and the rise of AI-driven design are reinforcing the increasing need for deep scientific expertise and innovation...

Biologics at a turning point: complexity, AI and the road to 2026

Read more
Finance Symbiosis Pharmaceutical Services (Symbiosis), a leading sterile fill-finish contract manufacturing organisation (CMO), has manufactured its first 10,000-vial batch at the...

Symbiosis begins commercial manufacturing at new FDA-inspected facility

Read more
Finance In December 2025, Gaelic Laboratories, a world-class manufacturer of beta-lactam (penicillin) products, acquired Athlone Laboratories, another leading developer and supplier of...

Building a beta-lactam powerhouse: Gaelic’s strategic leap with Athlone

Read more
Manufacturing Acquisition strengthens ITT’s position in industrial, chemical, energy, health and nutrition markets, adding high-margin revenue, major aftermarket growth and $80m in...

ITT to acquire SPX FLOW in $4.8bn deal, expanding global leadership in engineered components and flow technologies

Read more
Manufacturing New and expanded Bioprocess Design Centres will provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region

Thermo Fisher Scientific doubles down on investment in Asia

Read more
Finance The EIB and Angelini Ventures will co-invest €150 million to scale innovative European healthtech companies. The deal marks the EIB’s first partnership with a corporate...

EIB and Angelini Ventures launch €150m fund to boost European biotech, medtech and digital health startups

Read more
Finance A string of funding rounds and strategic financing deals across Europe’s life-sciences sector is breathing new life into companies working on high-need treatments — from...

Fresh capital flows into neurodegeneration, cancer and vascular-access developers

Read more
Finance Mark Minihane, UK&I Industrials and Energy Tax Leader for EY, comments on the industrial implications of the Chancellor’s Autumn Budget

Budget 2025: EY comments on the industrial impact of the Autumn Budget

Read more
Finance On 26 November, the Chancellor of the Exchequer, the Rt Hon Rachel Reeves MP, delivered the 2025 UK Autumn Budget

Response to Budget from the Institution of Chemical Engineers (IChemE)

Read more
Research & Development The University of Glasgow spin-out's malaria programme is moving towards IND enablement within the next 12 months and is designed to deliver a single-dose cure — a potential...

Gates Foundation awards Keltic Pharma $1.3 million for malaria drug research

Read more
Finance New tax breaks promise to fuel UK biotech scale-ups, but escalating workspace rates threaten to slow the momentum

UK bioindustry edges toward a critical turning point after the autumn budget

Read more
Finance Despite bold rhetoric, today’s Budget delivered little of the certainty, investment or strategic direction the UK life sciences sector urgently needs

Budget 2025: a missed opportunity for UK life sciences

Read more
Finance Fuelled by the GLP-1 boom, the drugmaker's stock has surged by more than 35% this year, with the company reaching a $1 trillion valuation on Friday — becoming the first...

Eli Lilly becomes first $1 trillion pharma company

Read more
Finance HitGen will use its DNA-encoded library platform to identify new drug leads for TB, malaria and non-hormonal contraception. The new Gates Foundation agreement expands on...

HitGen secures Gates Foundation funding to advance drug discovery for tuberculosis, malaria and contraception

Read more